v3.22.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2022
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended December 31, 

    

Six Months Ended December 31, 

    

2021

    

2022

2021

    

2022

Cost of goods sold

$

205

$

241

$

411

$

457

Selling, general and administrative

6,642

6,870

 

13,410

 

13,710

Research and development

127

128

 

267

 

249

Stock-based compensation expense

$

6,974

$

7,239

$

14,088

$

14,416

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2022

 

110,645

 

$

82.43

 

Granted

 

23,351

87.90

Exercised

 

(7,766)

68.07

Expired or forfeited

 

(1,515)

80.91

Outstanding at December 31, 2022

 

124,715

84.37

6.7 years

$

384

Exercisable at December 31, 2022

73,356

80.06

 

5.1 years

$

384

Schedule of stock option activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2022

 

427,447

$

90.17

Granted

 

356,110

89.11

Vested

 

(306,528)

96.38

Forfeited

 

(12,821)

88.87

Nonvested at December 31, 2022

 

464,208

$

85.29